MedTrace Logo

Cilostazol-Simvastatin Drug Interaction Study

NCT02431013 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-05-01

No results posted yet for this study

Summary

This is a randomized, open-label, single \& multiple-dose, parallel study to investigate the effect of cilostazol on the disposition of simvastatin \& pravastatin in healthy male volunteers

Conditions

Interventions

DRUG

Simvastatin

Simvastatin 40 mg on Day 1 \& Day 8.

DRUG

Pravastatin

Pravastatin 20 mg on Day 1 \& Day 8.

DRUG

Cilostazol

Cilostazol 100 mg twice a day for 6 days \& on Day 8 with statin.

Sponsors & Collaborators

  • Ajou University School of Medicine

    lead OTHER

Principal Investigators

  • Doo-Yeoun Cho, MD · Ajou University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2015-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02431013 on ClinicalTrials.gov